Immunoglobulin A vasculitis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:761D69.0
Who is this for?
Show terms as
4Active trials17Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Immunoglobulin A vasculitis (IgA vasculitis), formerly known as Henoch-Schönlein purpura (HSP), is the most common systemic vasculitis of childhood. It is characterized by inflammation of small blood vessels (small-vessel vasculitis) with deposition of IgA-containing immune complexes in affected tissues. The disease primarily affects the skin, gastrointestinal tract, joints, and kidneys. The hallmark clinical feature is palpable purpura — a raised, non-blanching rash typically distributed over the lower extremities and buttocks. Other key manifestations include abdominal pain (often colicky, sometimes accompanied by gastrointestinal bleeding), arthritis or arthralgia (particularly affecting the knees and ankles), and renal involvement ranging from mild hematuria and proteinuria to, in a minority of cases, progressive glomerulonephritis that can lead to chronic kidney disease. IgA vasculitis frequently follows an upper respiratory tract infection, and various infectious agents, medications, and environmental triggers have been implicated. The condition predominantly affects children between the ages of 3 and 10 years, though it can occur at any age. Adults tend to have more severe disease, particularly with regard to renal complications. The disease is generally self-limiting in children, with most cases resolving within weeks to months. Treatment is primarily supportive, including adequate hydration, rest, and nonsteroidal anti-inflammatory drugs (NSAIDs) for joint pain. Corticosteroids may be used for severe gastrointestinal symptoms or significant renal involvement. In cases of progressive nephritis, immunosuppressive agents such as cyclophosphamide, azathioprine, or mycophenolate mofetil may be considered. Long-term follow-up is recommended to monitor for renal complications, which represent the most important determinant of long-term prognosis.

Also known as:

Clinical phenotype terms— hover any for plain English:

Gastrointestinal infarctionsHP:0005244Infectious encephalitisHP:0002383Vascular skin abnormalityHP:0011276OrchitisHP:0100796
Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗NORD ↗

FDA & Trial Timeline

5 events
Jan 2026Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis

The Children's Hospital of Zhejiang University School of Medicine

TrialNOT YET RECRUITING
Jun 2025Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

Capital Institute of Pediatrics, China — PHASE4

TrialRECRUITING
Jan 2023Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University — NA

TrialRECRUITING
Mar 2022Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis

Hopital Foch — PHASE3

TrialACTIVE NOT RECRUITING
Sep 2019Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura

Children's Hospital of Fudan University — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Immunoglobulin A vasculitis.

4 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

4 recruitingView all trials with filters →
Phase 31 trial
Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis
Phase 3
Active
PI: Romain Paule, Dr (Hôpital Foch) · Sites: Brest; Clermont-Ferrand +12 more · Age: 1899 yrs
Phase 41 trial
Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Phase 4
Actively Recruiting
· Sites: Beijing, Beijing Municipality · Age: 318 yrs
N/A2 trials
Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura
N/A
Actively Recruiting
PI: Li Sun, MD (Children's Hospital of Fudan University) · Sites: Shanghai; Shanghai +1 more · Age: 216 yrs
Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura
N/A
Actively Recruiting
PI: Weiping Tan, PhD (Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Unive) · Sites: Guangzhou, Guangdong · Age: 318 yrs

Specialists

17 foundView all specialists →
RP
Radko Komers, MD, PhD
PORTLAND, OR
Specialist
PI on 5 active trials
CM
Carol A. Langford, MD, MHS
JAMAICA PLAIN, MA
Specialist
PI on 2 active trials
KL
Kristen Lee
Specialist
PI on 1 active trial535 Immunoglobulin A vasculitis publications
IP
Isabelle Koné-Paut, MD, PhD
Specialist
PI on 1 active trial
YP
Yang si rui, MD and PhD
Specialist
PI on 1 active trial
EM
Eric THERVET, MD
Specialist
PI on 1 active trial
TP
Tu Anh Tran, MD, PhD
Specialist
PI on 1 active trial
RD
Romain Paule, Dr
Specialist
PI on 1 active trial
WT
Weiping Tan
Specialist
PI on 1 active trial
LS
Li Sun
Specialist
PI on 1 active trial
MJ
Mao Jianhua
Specialist
PI on 1 active trial
EP
Evangeline PILLEBOUT
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Immunoglobulin A vasculitis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Immunoglobulin A vasculitisForum →

No community posts yet. Be the first to share your experience with Immunoglobulin A vasculitis.

Start the conversation →

Latest news about Immunoglobulin A vasculitis

1 articles
NewsRSSApr 22, 2026
Test Your Knowledge About Life Expectancy in AAV
This article invites people to take a quiz about life expectancy in AAV (ANCA-associated vasculitis), a rare disease that affects blood vessels. After completin
See all news about Immunoglobulin A vasculitis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Immunoglobulin A vasculitis

What is Immunoglobulin A vasculitis?

Immunoglobulin A vasculitis (IgA vasculitis), formerly known as Henoch-Schönlein purpura (HSP), is the most common systemic vasculitis of childhood. It is characterized by inflammation of small blood vessels (small-vessel vasculitis) with deposition of IgA-containing immune complexes in affected tissues. The disease primarily affects the skin, gastrointestinal tract, joints, and kidneys. The hallmark clinical feature is palpable purpura — a raised, non-blanching rash typically distributed over the lower extremities and buttocks. Other key manifestations include abdominal pain (often colicky, s

How is Immunoglobulin A vasculitis inherited?

Immunoglobulin A vasculitis follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Immunoglobulin A vasculitis typically begin?

Typical onset of Immunoglobulin A vasculitis is childhood. Age of onset can vary across affected individuals.

Are there clinical trials for Immunoglobulin A vasculitis?

Yes — 4 recruiting clinical trials are currently listed for Immunoglobulin A vasculitis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Immunoglobulin A vasculitis?

17 specialists and care centers treating Immunoglobulin A vasculitis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.